MedPath

Rural Colon Cancer Screening Toolkit Intervention

Not Applicable
Recruiting
Conditions
Colon Cancer Screening
Registration Number
NCT04651504
Lead Sponsor
Washington University School of Medicine
Brief Summary

Less than half of all positive fecal immunochemical testing (FIT)s are followed-up by colonoscopy, thus limiting the full potential of colorectal cancer (CRC) screening to reduce mortality. Given the need for coordination in order to achieve high rates of follow-up, multilevel approaches are needed. Such approaches could be particularly beneficial in communities and populations that experience cancer disparities and have fewer specialty providers, but most data focuses on large systems or urban areas. The academic-community health system collaboration is uniquely poised to address this research and service gap. The persistent poverty and health disparities in rural Southern Illinois set the stage for truly impactful research. The investigators' approach will serve as a model for multilevel interventions in rural settings, inform future work addressing other health disparities, and fill a gap in rigorous trials of CRC screening follow-up in rural areas.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
285841
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Number of colonoscopy completions after positive fecal immunochemical testCompletion of follow-up (estimated to be 44 months)

-Within 60 days of referral

Number of referrals for colonoscopies after positive fecal immunochemical testCompletion of follow-up (estimated to be 44 months)
Secondary Outcome Measures
NameTimeMethod
Proportion of participants who initiate a colonoscopy within 14 days of positive fecal immunochemical testCompletion of follow-up (estimated to be 44 months)
Time to colonoscopyCompletion of follow-up (estimated to be 44 months)
Proportion of patients who complete a complete diagnostic evaluation within 60 days of positive fecal immunochemical testCompletion of follow-up (estimated to be 44 months)

Trial Locations

Locations (1)

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

Washington University School of Medicine
🇺🇸Saint Louis, Missouri, United States
Aimee James, Ph.D., MPH
Principal Investigator
Graham Colditz, M.D., DrPH
Sub Investigator
Jean Hunleth, Ph.D., MPH
Sub Investigator
Michelle Silver, Ph.D.
Sub Investigator
Esther Lu, Ph.D.
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.